Association Between Exposure to Kampo Medicines Containing Ephedra and Major Congenital Malformations: A Japanese Administrative Claims Database Study
Traditional & Kampo Medicine · 2026-04 · 13 (1)
DOI: 10.1002/tkm2.70049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Traditional & Kampo Medicine, online erschienen am 25.03.2026. Verfasst von Satoko Suzuki und 16 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health, Labour and Welfare, Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Aim
Traditional Japanese (Kampo) medicines containing ephedra (KE) are prescribed for cold during pregnancy; however, detailed safety information on their use in pregnant women is lacking. This study aimed to clarify the association between prescription of KE during the first trimester of pregnancy and major congenital malformations (MCMs) in newborns.
Methods
Data from a large Japanese administrative claims database were analyzed: we included records of pregnant women who continued to be covered in the same health insurance society from 3 months before pregnancy until delivery, who gave birth between 2010 and 2019; the selected records included data relating to the infants until first year from birth. Pregnant women who were prescribed acetaminophen, commonly used to treat colds, in the first trimester of pregnancy and their infants were treated as the controls in our analysis.
Results
Of 75,398 infants, 4607 (6.1%) were diagnosed with MCMs within the first year of birth. Among the 7820 infants whose mothers were prescribed acetaminophen, 497 (6.4%) had MCMs. Of the 4772 infants were born to women prescribed KE, among whom 327 (6.9%) had MCMs. adjusting for covariates with propensity score overlap weights identified no significant difference in MCM risk between the two types of prescriptions (overlap‐weighted odds ratio 1.077, 95% confidence interval 0.932−1.245).
Conclusion
The results of this study indicated that the risk of MCMs did not differ between women prescribed KE and those prescribed acetaminophen in the first trimester of pregnancy.
Förderung
- Ministry of Health, Labour and Welfare
- Japan Society for the Promotion of Science
- Japan Agency for Medical Research and Development
Zitieren
APA
Suzuki, S., Arita, R., Obara, T., Ishikawa, T., Kunitoki, T., Sakai, T., Noda, A., Shinoda, G., Ishikuro, M., Orui, M., Kuriyama, S., Ohsawa, M., Haneda, K., Mano, N., Kikuchi, A., Takayama, S., & Ishii, T. (2026). Association Between Exposure to Kampo Medicines Containing Ephedra and Major Congenital Malformations: A Japanese Administrative Claims Database Study. Traditional & Kampo Medicine, 13(1). https://doi.org/10.1002/tkm2.70049
Vancouver
Suzuki S, Arita R, Obara T, Ishikawa T, Kunitoki T, Sakai T, et al. Association Between Exposure to Kampo Medicines Containing Ephedra and Major Congenital Malformations: A Japanese Administrative Claims Database Study. Traditional & Kampo Medicine. 2026;13(1). doi:10.1002/tkm2.70049
BibTeX
@article{Suzuki2026,
author = {Suzuki, Satoko and Arita, Ryutaro and Obara, Taku and Ishikawa, Tomofumi and Kunitoki, Tadaharu and Sakai, Takamasa and Noda, Aoi and Shinoda, Genki and Ishikuro, Mami and Orui, Masatsugu and Kuriyama, Shinichi and Ohsawa, Minoru and Haneda, Ken and Mano, Nariyasu and Kikuchi, Akiko and Takayama, Shin and Ishii, Tadashi},
title = {Association Between Exposure to Kampo Medicines Containing Ephedra and Major Congenital Malformations: A Japanese Administrative Claims Database Study},
journal = {Traditional & Kampo Medicine},
year = {2026},
volume = {13},
number = {1},
doi = {10.1002/tkm2.70049}
}
EUVIMED